Faroese group Bakkafost made a third quarter profit of DKK 199.6m, up from DKK 25.8m in 2012, but is now treating the potential amoeba gill disease carrier agent it discovered across multiple farms. [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.